Canadian court favors Pfizer in Lipitor case against Ranbaxy

09/14/2007 | Forbes

A Canadian court has handed out a decision preventing Indian drug giant Ranbaxy Laboratories Ltd. from selling a generic version of Pfizer's cholesterol-lowering drug Lipitor. At issue is a crystalline form of atorvastatin, an active ingredient in Lipitor, to which Pfizer has exclusive rights until 2016.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ